Anti-amyloid beta activity of intravenous immunoglobulin (IVIG) in vitro

Details for Australian Patent Application No. 2009222199 (hide)

Owner Baxter Healthcare S.A. Baxter International Inc.

Inventors Reipert, Birgit; Olas, Katarzyna; Schwarz, Hans-peter; Ehrlich, Hartmut

Agent Cullens

Pub. Number AU-A-2009222199

PCT Pub. Number WO2009/111240

Priority 61/032,874 29.02.08 US

Filing date 25 February 2009

Wipo publication date 11 September 2009

International Classifications

G01N 33/50 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

G01N 33/68 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving proteins, peptides or amino acids

Event Publications

9 September 2010 PCT application entered the National Phase

  PCT publication WO2009/111240 Priority application(s): WO2009/111240

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009222202-Dehumidifier apparatus and method

2009222198-Pyrrolidine derivatives